Michal Hlaváč

Also affiliated with University Hospital Ulm, Technische Hochschule Ulm

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Tumor Treating Fields (TTFields) combined with the drug repurposing approach CUSP9v3 induce metabolic reprogramming and synergistic anti-glioblastoma activity in vitro”.

Tumor Treating Fields (TTFields) combined with the drug repurposing approach CUSP9v3 induce metabolic reprogramming and synergistic anti-glioblastoma activity in vitro

British Journal of Cancer(2024)10.1038/s41416-024-02608-8

N/A

0.511DataRank · unranked

13 citations

Annika Hajosch, Richard E. Kast, C Loehmann, Michal Hlaváč, Pamela Fischer‐Posovszky +7 more

Dual metabolic reprogramming by ONC201/TIC10 and 2-Deoxyglucose induces energy depletion and synergistic anti-cancer activity in glioblastoma

British Journal of Cancer(2020)10.1038/s41416-020-0759-0

N/A

0DataRank · unranked

54 citations

Annika Dwucet, Mine Tanriover, Michal Hlaváč, Richard E. Kast, Klaus‐Michael Debatin +6 more